Log in  First Connection?

BreastArchives

Cultural adaptation of the fear of cancer recurrence therapy (FORT) for Turkish breast cancer survivors
Breast
 1 min.

 Published on 28/07/2026 |  Original article (Full-text)  | Eyrenci, Asl? et al. | BMC Psychology. Volume 14(1).

Fear of cancer recurrence (FCR) is a common concern among breast cancer survivors in Turkiye. Despite its clinical relevance, culturally adapted interventions are scarce. This study aimed to adapt the Fear of Recurrence Therapy (FORT), a structured group-based intervention, for Turkish breast cancer...

Liquid crystal thermography for breast cancer detection: principles, current evidence, limitations, and future directions
Breast
 1 min.

 Published on 21/07/2026 |  Original article (Full-text)  | Mohd Sha'ari, Ainnur Bazilah et al. | Journal of the Egyptian National Cancer Institute. Volume 38(1).

Breast cancer remains a leading cause of cancer-related mortality in women worldwide, making early and accurate detection a global clinical priority. Conventional screening modalities, including mammography, ultrasonography, and Magnetic Resonance Imaging (MRI), each have well-established strengths and...

Relationship between social capital and depression among middle-aged and older patients with breast cancer in China: mediating effect of posttraumatic growth
Breast
 1 min.

 Published on 14/07/2026 |  Original article (Full-text)  | Su, Jun et al. | BMC Psychology. Volume 14(1).

To improve psychological care among middle-aged and older patients with breast cancer in China, more information is needed on social capital, posttraumatic growth (PTG), and depression among breast cancer patients in China. Objective: To identify the relationships among social capital, PTG, and depression...

Cardiotoxicity of monoclonal antibody-based therapies in breast cancer: a contemporary narrative review
Breast
 1 min.

 Published on 07/07/2026 |  Original article (Full-text)  | Santos Nussbaum, Ana Cláudia Aparecida et al. | Cardio-Oncology. Volume 12(1).

Monoclonal antibody-based therapies have substantially improved outcomes in breast cancer, particularly through HER2-directed treatment strategies, but have also introduced important cardiovascular toxicities that require careful recognition and management. This narrative review summarizes current evidence...